Index | Recent Threads | Unanswered Threads | Who's Active | Guidelines | Search |
![]() |
World Community Grid Forums
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
No member browsing this thread |
Thread Status: Active Total posts in this thread: 530
|
![]() |
Author |
|
l_mckeon
Senior Cruncher Joined: Oct 20, 2007 Post Count: 439 Status: Offline Project Badges: ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Mannose suger slows the growth of tumor cells and can synergize with chemotherapy.
A series of experiments revealed that mannose + drug worked by inducing programmed cell death (called apoptosis). Specifically, it altered the levels of three proteins that regulate a cell death pathway, which they do by controlling how easily things can get into and out of the mitochondria. Further experimentation indicated that fewer of these proteins are made in the presence of mannose + drug. The authors wondered if these effects that they’d seen in tissue culture dishes could be recapitulated in vivo. They fed mannose to mice with tumors, and it slowed tumor growth and enhanced chemotherapy in the mice, too. It did not cause weight gain or otherwise impact the health of the mice. They went on to probe why some tumor cells are more sensitive to mannose than others. They found that mannose sensitivity was inversely proportional to the levels of an enzyme that helps metabolize mannose. Knocking down the enzyme in tumor cell lines made any cell sensitive to mannose. The researchers looked at a panel of human cancers—ovarian, renal, breast, prostate, colorectal—and saw that the enzyme varied among them, but had no prognostic significance (probably because there’s usually not that much mannose around, especially relative to glucose). Colorectal tumors tend to have especially low levels so might be good candidates for initial treatments with the sugar. https://arstechnica.com/science/2018/11/sugar...one-sugar-may-help-chemo/ |
||
|
Jim Slade
Veteran Cruncher Joined: Apr 27, 2007 Post Count: 665 Status: Offline Project Badges: ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Use of Next-Generation Sequencing Tests to Guide Cancer Treatment: Results From a Nationally Representative Survey of Oncologists in the United States/ JCO Precision Oncology
There are no nationally representative data on oncologists use of next-generation sequencing (NGS) testing in practice. The purpose of this study was to investigate how oncologists in the United States use NGS tests to evaluate patients with cancer and to inform treatment recommendations. In 2017, most oncologists in the United States were using NGS tests to guide treatment decisions for their patients. More research is needed to establish the clinical usefulness for these tests, to develop evidence-based clinical guidelines for their use in practice, and to ensure that patients who can benefit from these new technologies receive appropriate testing and treatment. http://ascopubs.org/doi/10.1200/PO.18.00169 ![]() |
||
|
TheBizii
Advanced Cruncher Slovenia Joined: Jan 4, 2016 Post Count: 51 Status: Offline Project Badges: ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Scientists may have found a way to treat cancer without chemotherapy by replicating our body's own self-destruct system
Every day, millions of cells in our bodies "kill" themselves and are quickly removed. While the mechanism may sound dramatic, it's for our own good. The process ensures that potentially harmful cells destroy themselves and protects us from diseases. Cancer cells, however, can protect themselves from self-destruction by ignoring our immune system's cell-death signals — and that's precisely what makes them so dangerous. https://www.businessinsider.com/scientists-ma...a&utm_medium=referral |
||
|
l_mckeon
Senior Cruncher Joined: Oct 20, 2007 Post Count: 439 Status: Offline Project Badges: ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Two experimental cancer drugs team up after unexpected discovery
----------------------------------------Researchers at MIT have used two experimental cancer drugs in tandem to fight melanomas. The team paired protein kinase inhibitors with ribonuclease drugs and set them loose onto tumors, and found that the combination worked better than either drug does alone [and with lower doses]. The discovery could help reduce side effects of cancer treatments and make them more effective. More at: https://newatlas.com/two-experimental-cancer-drugs-team-up/57504/ [Edit 1 times, last edit by l_mckeon at Dec 4, 2018 11:37:21 PM] |
||
|
l_mckeon
Senior Cruncher Joined: Oct 20, 2007 Post Count: 439 Status: Offline Project Badges: ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Researchers find potential 10 minute test for all cancers -- 90 per cent success rate.
Researchers have discovered a curious difference between the DNA from cancer cells and that from healthy cells, and this finding could lead to a new blood test for cancer. The difference? Cancer DNA has a rather strong affinity for gold, according to a new study. This feature appears to be common to cancer DNA in general, regardless of the type of cancer, the researchers said. Taking advantage of this finding, the researchers designed a new test that uses gold nanoparticles to detect cancer. The gold particles change color depending on whether or not cancer DNA is present. The result was a simple and fast [color change] test that could detect cancer in just 10 minutes, according to the study, published today (Dec. 4) in the journal Nature Communications. "You can detect it by eye — it's as simple as that," study senior author Matt Trau, a professor and senior group leader at the University of Queensland's Australian Institute for Bioengineering and Nanotechnology, said in a statement. However, the work is preliminary, and much more research is needed before this test could be useful for patients, outside experts told Live Science. https://www.livescience.com/64234-cancer-dna-gold-new-test.html |
||
|
l_mckeon
Senior Cruncher Joined: Oct 20, 2007 Post Count: 439 Status: Offline Project Badges: ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Aspirin could help treat a condition commonly dubbed “chemo brain” in breast cancer treatment.
----------------------------------------The condition, which causes problems with memory, learning and concentration, affects up to 60 percent of breast cancer patients who have undergone chemotherapy. According to a new study funded by the National Breast Cancer Foundation however, chemo brain could be treated with something as simple as aspirin. Dr Adam Walker of Neuroscience Research Australia said that while the tumour itself can cause cognitive impairment, the breast cancer cells release markers that can cause inflammation. Experiments involving mice show aspirin can help negate the effects of chemo brain. “So it was very exciting to see that with aspirin we were able to completely prevent and block memory impairment occurring,” he said. Dr Walker is now working to see whether the drug can reverse the long-term effects of the condition. His research marks the first time researchers have been able to show the use of anti-inflammatories in combating this particular problem. Dr Walker’s findings could also apply to other cancers. https://www.9news.com.au/2018/12/09/04/45/bre...-aspirin-treatment-health [Edit 1 times, last edit by l_mckeon at Dec 9, 2018 11:48:27 PM] |
||
|
l_mckeon
Senior Cruncher Joined: Oct 20, 2007 Post Count: 439 Status: Offline Project Badges: ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Australian researchers are leading an international project to test if the use of some anesthetic gases in surgery for colorectal and lung cancer dramatically increases the likelihood of relapse, as opposed to intravenous anesthetics. Apparently there have been experiments on mice plus clinical observations leading to these suspicions.
----------------------------------------The increase in relapses could be as high as 50%, so it shouldn't take long for a test with a control group to see an effect, if true. I just accessed a search engine to get references on this and apparently much information on the affects of different anesthetic types on different cancers is already known and discussed. Some anesthetics actively suppress the immune system and thereby assist metastasis. Anyone needing to go in for cancer surgery should access The Duck or Mr Google before surgery and discuss this with your surgeon and anesthesiologist. l_mckeon [Edit 1 times, last edit by l_mckeon at Dec 10, 2018 12:22:46 AM] |
||
|
Jim Slade
Veteran Cruncher Joined: Apr 27, 2007 Post Count: 665 Status: Offline Project Badges: ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
100,000 whole genomes sequenced in the NHS
The 100,000 Genomes Project has sequenced 100,000 whole genomes, helping to improve diagnosis and treatment for patients with rare diseases and cancer. It is led by Genomics England and NHS England. https://www.gov.uk/government/news/100000-whole-genomes-sequenced-in-the-nhs ![]() |
||
|
l_mckeon
Senior Cruncher Joined: Oct 20, 2007 Post Count: 439 Status: Offline Project Badges: ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Unlikely drug pair combine to cut off cancer's energy supply
Molecular scientists at the University of Basel actually discovered two years ago that a commonly used diabetes drug could be combined with a 50-year-old hypertension medication to inhibit tumor growth. Named metformin and syrosingopine, respectively, the scientists knew beforehand that the former had some anti-cancer properties, but only by mixing it with the latter did it seem to have any meaningful effect. They have now carried out follow-up experiments in mice to better understand how this process slows cancer growth, and it centers on a molecule called NAD+ that is central to converting nutrients into energy. NAD+ is produced through two cellular pathways, one of which metformin was known to block. The other, it has now been found, can be shut down by syrosingopine's ability to cause bottlenecks in some very key areas. [Previous concentrations of metformin alone required to have an anti-cancer effect are at least an order of magnitude above dosages for diabetes. It's hoped the synergy with the second drug will allow the metformin dose to be greatly reduced.] More at: https://newatlas.com/drug-pair-cancer-energy/57623/ |
||
|
l_mckeon
Senior Cruncher Joined: Oct 20, 2007 Post Count: 439 Status: Offline Project Badges: ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Epigenetics based screening method for cervical cancer -- maybe more accurate and cheaper.
The new epigenetics-based screening method proved successful in predicting 100 percent of the eight different types of cervical cancer to occur in 15,744 subjects. The Pap smear detected 25 percent of the cancers, while the HPV test detected 50 percent. In a subset of 257 HPV-positive women, the new test detected 93 percent of pre-cancerous lesions, compared to an accuracy of 86 percent provided by the Pap smear and HPV test combined. "This really is a huge advance in how to deal with HPV-infected women and men, numbering in the billions worldwide, and it is going to revolutionize screening," says lead researcher Attila Lorincz. "We were surprised by how well this new test can detect and predict early cervical cancers years in advance, with 100 per cent of cancers detected, including adenocarcinomas, which is a type of cervical cancer that is very difficult to detect." Not only does it appear to be much more accurate, it would also be cheaper than a Pap smear if fully implemented, though the researchers don't expect that to happen for at least five years. But the research also has immediate implications, as it sheds new light on how cancers could be shaped by epigenetics, a scientific field we are learning more and more about all the time. More at: https://newatlas.com/perfect-cancer-screening-results-epigenetics/57714/ |
||
|
|
![]() |